- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/22 - Ribonucleases
Patent holdings for IPC class C12N 9/22
Total number of patents in this class: 12433
10-year publication summary
351
|
487
|
724
|
919
|
1168
|
1265
|
1400
|
1692
|
1828
|
852
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19812 |
530 |
The Broad Institute, Inc. | 1785 |
489 |
Massachusetts Institute of Technology | 10013 |
448 |
President and Fellows of Harvard College | 5949 |
448 |
Sangamo Therapeutics, Inc. | 415 |
169 |
The General Hospital Corporation | 4704 |
156 |
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 310 |
149 |
The Board of Trustees of the Leland Stanford Junior University | 6365 |
146 |
Cellectis | 406 |
144 |
Pairwise Plants Services, Inc. | 240 |
142 |
CRISPR Therapeutics AG | 361 |
137 |
Arbor Biotechnologies Inc. | 163 |
137 |
Editas Medicine, Inc. | 250 |
133 |
Pioneer Hi-Bred International, Inc. | 6486 |
122 |
Beam Therapeutics Inc. | 232 |
118 |
Novozymes A/S | 3309 |
111 |
Regeneron Pharmaceuticals, Inc. | 4223 |
110 |
Duke University | 3058 |
105 |
Precision Biosciences, Inc. | 180 |
104 |
University of Massachusetts | 2218 |
101 |
Other owners | 8434 |